Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.

Liver international : official journal of the International Association for the Study of the Liver - 1 Feb 2013

Zoulim Fabien, Locarnini Stephen

Abstract excerpt

The management of treatment failure in patients with chronic hepatitis B, remains a clinical concern. Incomplete viral suppression and the emergence of drug resistance are key determinants of treatment failure. The correct choice of a potent first-line therapy to achieve sustained long-term suppression of viral replication provides the best chance of preventing treatment failure and drug resistance. Clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Genotype

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to Time Factors

Share to Treatment Failure

Source

Identifiers

PMID: 23286855
DOI: 10.1111/liv.12069

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.PMID 23286855Read ↗

Management of antiviral drug resistance in chronic hepatitis B.Semantic proximity Read ↗

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade.Semantic proximity Read ↗

Chronic hepatitis B: preventing, detecting, and managing viral resistance.Semantic proximity Read ↗

Antiviral‐resistant hepatitis B virus: can we prevent this monster from growing?Semantic proximity Read ↗

Prevention and management of drug resistance for antihepatitis B treatment.Semantic proximity Read ↗

Treatment for hepatitis B in patients with drug resistanceSemantic proximity Read ↗

Management and prevention of drug resistance in chronic hepatitis B.Semantic proximity Read ↗

How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting.Semantic proximity Read ↗

The emerging field of HCV drug resistanceSemantic proximity Read ↗

Mechanisms of Virologic Failure with Direct-Acting Antivirals in Hepatitis C and Strategies for Retreatment.Semantic proximity Read ↗

Treatment failure with new hepatitis C drugs.Semantic proximity Read ↗

Resistance to direct antiviral agents in patients with hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.